..BE..DE..ESFRGB..IT............................................................JDIM360 (Ver 1.5 21 Nov 2005) - 2999001/0The file contains technical information submitted after the application was filed and not included in this specification200503031138329CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120060517W10000000072deBibliographieenBibliographyfrBibliographieEP01107235.2199002152001041720030128enenen354368919890215JP2006051720062020011004200140200406022004232003090420060517200620A61K 31/44 19850101AFI20020214BHEP A61P 43/00 20000101ALI20020214BHEP deZusammensetzung, welche 5-Methyl-1-phenyl-2-(1 H)-pyridone enthält, zur fixierung und Vermeidung von fibrotischen SchädigungenenComposition containing 5-Methyl-1-phenyl-2-(1 H)-pyridone for reparation and prevention of fibrotic lesionsfrComposition, qui contient 5-Methyl-1-phenyl-2-(1 H)-pyridone, pour réparer et prévenir des lésions fibrotiquesUS-A- 4 042 699MARGOLIN: "removal of interstitial chemotherapy..." FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY, vol. 41, no. 5, 1982, XP008000826 new orleansROBERTS: "pirfenidone" DRUGS OF THE FUTURE, vol. 11, no. 6, - 1977 pages 396-397, XP008000834NONE90301607.9038359119900215Margolin, Solomon B.6723 Desco DriveDallas, Texas 75225USYamauchi, Shitotomo01200020DGB/EPC-786c/o KDL INC., Central Bldg. Ichibancho 22-1Chiyoda, Tokyo 102JPMARGOLIN, Solomon B.01275780DGB/EPC-7866723 Desco DriveDallas, Texas 75225USBannerman, David Gardneret al00028001Withers & Rogers LLP Goldings House, 2 Hays LaneLondon SE1 2HWGBBEDEESFRGBIT20020417200216